Safe Orthopaedics - Stock

Safe Orthopaedics ROE 2024

Safe Orthopaedics ROE

5.45

Safe Orthopaedics Dividend yield

Ticker

ALSAF.PA

ISIN

FR0013467123

WKN

A2PW9B

In 2024, Safe Orthopaedics's return on equity (ROE) was 5.45, a -132.31% increase from the -16.86 ROE in the previous year.

Safe Orthopaedics Aktienanalyse

What does Safe Orthopaedics do?

Safe Orthopaedics SA is a leading company in the development and manufacturing of innovative medical devices for orthopedic surgery. The company was founded in 2010 by Pierre Dumouchel and Didier Toubia and has its main office in Eragny-sur-Oise, France. The company's business model is based on the development of products that can improve the lives of patients suffering from back injuries, osteoporosis, bone tumors, spinal trauma, or other orthopedic conditions. Safe Orthopaedics focuses on developing safe, easy-to-use, and cost-effective solutions for patient care. The company has several divisions, including the development and manufacturing of implantable spinal products and the development of innovative instruments for minimally invasive surgery. Safe Orthopaedics is also known for its custom surgical sets that are specifically tailored to the needs of its customers. Safe Orthopaedics offers a wide range of innovative products for orthopedic surgery. The company is particularly known for its spinal implants, including the SteriSpine® product range. The SteriSpine® system consists of a variety of sterile, implantable materials for use in spinal surgery. The system includes a variety of screws, plates, rods, and other implants that can be used to stabilize the spine in patients with spinal injuries or other conditions. Safe Orthopaedics also has an extensive portfolio of specialized instruments for minimally invasive surgery, enabling gentle and precise treatment. These include instruments such as the SteriFuse™ fusion tube, which allows for gentle fusion of vertebrae, or the SteriStay™, a device for stabilizing the spine. Custom surgical sets are also manufactured by Safe Orthopaedics. These sets are specifically tailored to the requirements of the corresponding spinal surgery, making the work of surgeons easier and contributing to patient safety. In 2019, Safe Orthopaedics acquired LCI Medical, a company specialized in the development of surgical instruments for minimally invasive spinal operations. By acquiring LCI Medical, Safe Orthopaedics expanded its range of products for minimally invasive spinal surgery and thus strengthened its competitiveness in the orthopedic surgery market. In conclusion, Safe Orthopaedics SA enables state-of-the-art technologies and innovative solutions for patients with orthopedic conditions. The company is committed to prioritizing patient safety and wellbeing while ensuring that surgical impact is minimized through the use of minimally invasive surgery. With its cutting-edge products and services, the company can offer a comprehensive range of solutions for spinal injuries while remaining particularly focused on the needs of patients and surgeons. Safe Orthopaedics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Safe Orthopaedics's Return on Equity (ROE)

Safe Orthopaedics's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Safe Orthopaedics's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Safe Orthopaedics's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Safe Orthopaedics’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Safe Orthopaedics Stock

What is the ROE (Return on Equity) of Safe Orthopaedics this year?

The ROE of Safe Orthopaedics this year is 5.45 undefined.

How has the Return on Equity (ROE) of Safe Orthopaedics developed compared to the previous year?

The ROE of Safe Orthopaedics has increased by -132.31% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Safe Orthopaedics?

A high ROE indicates that Safe Orthopaedics generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Safe Orthopaedics?

A low ROE can indicate that Safe Orthopaedics is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Safe Orthopaedics affect the company?

A change in ROE (Return on Equity) of Safe Orthopaedics can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Safe Orthopaedics?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Safe Orthopaedics?

Some factors that can influence Safe Orthopaedics's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Safe Orthopaedics pay?

Over the past 12 months, Safe Orthopaedics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Safe Orthopaedics is expected to pay a dividend of 0 EUR.

What is the dividend yield of Safe Orthopaedics?

The current dividend yield of Safe Orthopaedics is .

When does Safe Orthopaedics pay dividends?

Safe Orthopaedics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Safe Orthopaedics?

Safe Orthopaedics paid dividends every year for the past 0 years.

What is the dividend of Safe Orthopaedics?

For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.

In which sector is Safe Orthopaedics located?

Safe Orthopaedics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Safe Orthopaedics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Safe Orthopaedics from 6/5/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 6/5/2024.

When did Safe Orthopaedics pay the last dividend?

The last dividend was paid out on 6/5/2024.

What was the dividend of Safe Orthopaedics in the year 2023?

In the year 2023, Safe Orthopaedics distributed 0 EUR as dividends.

In which currency does Safe Orthopaedics pay out the dividend?

The dividends of Safe Orthopaedics are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Safe Orthopaedics

Our stock analysis for Safe Orthopaedics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Safe Orthopaedics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.